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Cervicofacial lymphadenitis caused by nontuberculous mycobacteria (NTM) is commonly treated 
with surgery or antimicrobial therapy. The aim of this study was to analyze the utility of our new 
blood-based diagnostic method and the treatment protocol, surgery or observation alone, in NTM 
lymphadenitis in children. 
Methods 
All patients under 16 years of age with cervicofacial NTM lymphadenitis diagnosed and treated at 
Children’s Hospital or at the Department of Otorhinolaryngology, Helsinki University Hospital 
(Helsinki, Finland) in 2007-2017 were retrospectively r viewed.  
Results 
Fifty-two patients, 33 (63%) of whom were girls, were included in the study. The median age at 
initial presentation of the NTM lymphadenitis was 2.9 years. The novel blood-test had been 
performed on 49 (94%) of the patients and in all of them it was indicative of NTM infection. A 
sample for mycobacterial culture was available from 34 patients, and Mycobacterium avium was the 
most common species detected. Most patients (n=33, 63%) were treated conservatively with 
observation alone. Of these, nine patients (27%) did not develop a skin fistula, and the 
lymphadenitis resolved without drainage.  
Conclusions 
The novel blood test is clinically feasible method f r diagnosing childhood cervicofacial NTM 
lymphadenitis noninvasively. Observation alone is a good alternative to surgery, without the risk of 
complications.  
 







Nontuberculous mycobacteria (NTM) are abundant microbes found in soil and water. NTM and 
Mycobacterium tuberculosis (MTB) are closely related. Therefore, Bacillus Calmette-Guérin 
(BCG) vaccine prevents NTM infections as well as childhood tuberculosis (TB). In Finland, 
universal BCG vaccinations were discontinued in 2006. Consequently the BCG coverage of infants 
dropped from >98 % to an estimated 6%, andchildhood NTM infections increased drastically.1 A 
similar increase has been observed previously, e.g. in Sweden.2   
In children, NTM infection typically affects cervicofacial lymph node(s). The clinical presentation 
is distinctive; a painless lump in the neck or parotid area, which in weeks/months turns into a 
red/purple lesion that eventually can burst and drain. Typically, the child is otherwise 
asymptomatic.  
Due to lack of conclusive studies, the treatment of ch ice for NTM lymphadenitis remains 
undefined. For decades, the gold standard of treatment for NTM lymphadenitis has been surgical 
removal of the infected lymph node. Another widely used approach is a lengthy treatment with 
antibiotic combinations. In a randomized controlled trial comparing these treatment options, cure 
was achieved earlier with surgery. However, surgical complications were seen in 28% and adverse 
effects of antimicrobials in 78% of the patients.3 There is increasing evidence from observational 
studies that the infection resolves spontaneously without any treatment. In 2008, Zeharia et al. 
published a study with 92 children treated with a conservative, observation-only approach.4 The 
infection resolved without any complications within o e year in all of the patients. In a recent meta-
analysis of 1951 children treated with surgery, antibiotics, or observation alone, complete excision 
had the highest mean cure rate, but also a 2% risk of a serious complication, permanent facial nerve 
palsy. Furthermore, antimicrobial treatment had more side-effects, but no benefits compared with 
observation alone.5 However, only 8% of the patients were in the observation-only group.  
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In our hospital, in-house modifications made to the commercial T-SPOT.TB blood test include an 
additional purified protein derivative (PPD) antigen stimulation.6 Currently, the modified test is a 
routine, noninvasive, investigation for children with suspected NTM lymphadenitis. Our treatment 
approach for childhood NTM lymphadenitis is either r moval of the infected lymph node(s) or 
observation alone.  
In this study we evaluate the outcomes of a single tertiary-care hospital treatment protocol – surgery 
or observation only – of cervicofacial NTM lymphadenitis in children. The aim was to describe the 
variety of clinical symptoms and healing process, epecially drainage duration in our population, 
and whether either of the protocols was superior when comparing the outcome, symptoms or 
amount of complications, in order to change our approach accordingly. 
 
2. Materials and Methods 
We conducted a retrospective review of medical records f all patients under 16 years of age with 
cervicofacial NTM lymphadenitis diagnosed and treated at the Children’s Hospital and at the 
Department of Otorhinolaryngology – Head and Neck Surgery, Helsinki University Hospital 
(Helsinki, Finland) from January 1, 2007 to May 31,2017. The search was based on the ICD-10 
diagnosis code for cervicofacial lymphadenitis (L04.0) and other mycobacterial infection (A31.9 
and A31.89).  
The diagnosis of NTM lymphadenitis was defined as 1) a typical clinical history and appearance of 
cervicofacial NTM lymphadenitis and 2) a positive modified T-SPOT.TB test result and/or NTM 
detected in cultures. Typical clinical appearance was defined as cervicofacial lymphadenitis in an 
otherwise healthy child, starting with a painless lump in the neck or parotid area and proceeding to a 




2.1 Diagnostic protocol 
In Finland, children with prolonged lymphadenopathy are referred to a pediatrician or specialist in 
otorhinolaryngology (ORL). If NTM lymphadenitis is suspected based on clinical history and 
findings, our primary diagnostic test is a novel modified T-SPOT.TB blood test.  
Briefly, the commercial T-SPOT.TB is an i  vitro interferon gamma release assay (IGRA) test used 
to diagnose TB infection. First, peripheral blood mononuclear cells (PBMCs) containing T cells are 
separated from a blood sample. Second, PBMCs are stimula ed in a well with a specific antigen (i.e. 
peptide mixture). If the T cells are sensitized to the antigen (i.e. the patient carries infection), they 
secrete interferon gamma (INF-γ). Third, the secreted INF-γ is captured in the well and visually 
detected as spots that are enumerated. If the number of spots (i.e. individual reacting T cells) 
exceeds the set cut-off value, the antigen reaction is considered positive. Because antigen 
stimulations are performed in separate wells, the reaction for each antigen can be measured 
separately.  
The commercial test contains antigens that are MTB-specific. Uniquely, our modified T-SPOT.TB 
test includes additional stimulation with PPD antigen. PPD is commonly used in the tuberculin skin 
test (TST) and contains a mixture of proteins that are present in MTB, Mycobacterium bovis BCG, 
and NTM. Therefore, a positive antigen reaction to PPD and negative reaction to MTB-specific 
antigens in the test can indicate either BCG vaccinatio  or NTM infection.  
After the 2006 BCG vaccine policy change and the subsequent increase in childhood NTM 
infections, the test appeared promising and useful for diagnosing NTM lymphadenitis in non-BCG-
vaccinated children (estimated sensitivity of 100% and specificity of 81%).6  In our hospital the test 
became a part of the diagnostic scheme for childhoo NTM lymphadenitis; the rationale is that in a 
non-BCG-vaccinated child presenting with a typical clinical and sonographic appearance of NTM 
lymphadenitis, a positive reaction to PPD alone indicates NTM infection. If the clinical presentation 
6 
 
is unusual, bacterial typing is required, or the modified T-SPOT.TB test is negative, or if a sample 
can be obtained easily from a draining fistula, furthe  investigations include mycobacterial cultures 
and/or histological examination. 
 
2.2 Treatment protocol 
In our hospital, after diagnosis of NTM cervicofacil lymphadenitis, the natural course of the 
disease and the treatment options are discussed with the parents. Infected lymph nodes are 
surgically removed if the risk of surgical complication is low (e.g. facial nerve damage) and the 
parents favor surgery. If a bacterial or histological specimen is needed due to unusual clinical 
presentation and/or unconfirmed laboratory test, fine needle biopsy or surgery is warranted. If the 
risk of surgical complications is high (e.g. lymph nodes in the parotid area or near facial nerve) or 
the parents do not favor surgery, the patients are followed without antimicrobial treatment with 
regular visits (e.g. every 1-4 months) until resoluti n of the lymphadenitis.  
 
2.3 Ethics 
The study protocol was approved, and institutional research permission was granted by the 
Department of Otorhinolaryngology, Helsinki University Hospital, Helsinki, Finland.  
 
3. Results 
3.1 Patient demographics and clinical presentation   
We identified 52 patients (33 female and 19 male) with cervicofacial NTM lymphadenitis who met 
the inclusion criteria (Table 1). The median age at time of initial presentation was 2.9 years (Figure 
1). The median parent-reported duration of symptoms until the first contact at our hospital was 25 
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days. Most of the patients (n=40) were seen by botha pediatrician and a specialist in ORL. The 
most affected nodal region was the upper neck/chin (levels I-II). No lymph node manifestations 
other than cervicofacial lymph node manifestations were presented. Histological sample was 
available for 24 patients (46%), and the most common finding was granulomatous infection. The 
median active follow-up was 8.2 months. During thisime the patients were seen at the outpatient 
clinic six times on average. The passive follow-up time was 3.7 years (until May 31, 2018).  
 
3.2 Microbiological culture and modified T-SPOT.TB INF-γ release assay test  
A sample for mycobacterium culture from the infected lymph node (drainage or tissue sample) was 
available from 34 (65%) of the patients. Cultures yielded NTM in 19 of the cases and an 
unspecified acid-fast rod in one case. Detected species were Mycobacterium avium (15 children), 
M. malmoense (2 children), M. interjectum (1 child), M. intracellulare and M. simiae (1 child).   
Altogether 49 patients (94%) were tested with the modified T-SPOT.TB test. All of them had a 
positive reaction on PPD stimulation and negative reactions on MTB-specific antigens indicative of 
NTM infection. The three patients not tested with the modified T-SPOT.TB had an NTM isolation 
in mycobacterial cultures.  
 
3.3 Clinical course, observation group 
Initial treatment was observation alone for 33 (63%) patients. Of these, nine patients (27%) did not 
develop a skin fistula, and the lymphadenitis resolved without drainage (Table 2). A fine needle 
biopsy (FNB) was obtained from 14 patients through intact skin for bacterial culture and cytologic 
analysis. After FNB, fistulization did not occur in three patients, ten patients had drainage, and for 
one patient there is no data available regarding fistula formation (Table 2). Drainage via fistula was 
mostly intermittent; some drainage appeared for days between longer periods without drainage. The 
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maximum time for intermittent drainage was one year. The NTM species did not seem to affect the 
drainage duration or fistula development; M. avium was the most common species, found in patients 
presenting at both ends of the clinical healing process (Table 2).  
Of the 33 patients in the observation alone group, nly one patient had scarring, which later needed 
surgical treatment for esthetic reasons. Another patient had recurrent lymph node swelling and the 
lymph node was later removed surgically. 
 
3.4 Surgery group 
Surgical intervention was performed on 19 patients (37% of all the study patients); in 6 patients the 
affected lymph node(s) were excised and 13 were treated with incision and curettage (Table 3). 
Incision and curettage was performed in order to empty large draining lymph node to shorten the 
duration of drainage, or if bacterial or histological specimen was needed from a lymph node with 
indurated skin, but the risk of surgical complication would have been high for excision of the whole 
lymph node. After small incision to indurated skin the curettage was done with a small scoop to 
remove soft, necrotic tissue inside the lymph node without puncturing the capsule.  
Two patients had more than one operation; one patient had excision of three lymph nodes first and 
later incision and curettage, and another patient had curettage twice. Two patients had postoperative 
infection and one patient postoperative hematoma. No complications affecting the function of the 
facial nerve were seen. Patients treated with excision presented no post-operative drainage. In 
curettage group, drainage lasted up to two months i seven patients, two patients had drainage more 
than two months and one more than six months. Three pati nts had no drainage. The number of 
patients was too small for any statistical analysis, but the dispersion of the drainage duration was 





The current treatment protocol of childhood NTM lymphadenitis, surgery or observation alone, has 
been in use for last ten years in our hospital. This retrospective study revealed that most of our 
patients (n=33, 63%) had been observed only without antimicrobial therapy and the lymphadenitis 
resolved spontaneously without complications. Although prolonged drainage lasting for months is 
feared consequence in NTM lymphadenitis, in our observation group in 14 children (42%) the 
drainage was minimal (less than two weeks) or none. 
Our patient demographics compare well with those report d earlier. NTM lymphadenitis mostly 
affects children of under school age.2,7 For an unknown reason, females are over-represented in our 
cohort, as also reported earlier from Finland and other countries.1,8–11  
Previously, BCG vaccination coverage in Finland wasexcellent (>98%) and childhood NTM 
lymphadenitis was extremely rare.1 At the time the change in BCG vaccination program took place 
NTM infections were unfamiliar to the clinicians. Therefore, the diagnosis was challenging and 
biopsies were performed as a routine part of the inv stigations. After adoption of the modified T-
SPOT.TB test as a diagnostic tool for NTM lymphadenitis, the need for biopsies quickly 
diminished. This novel blood test has been essential for noninvasive diagnostics and dramatically 
changed our diagnostic and treatment protocols; the diagnosis can be achieved in few days after 
which the treatment outlines can be discussed with the parents.  
Bacterial culture is still considered the gold stand rd diagnostic test for NTM infections, but limited 
by slow growth and poor sensitivity.12 Novel techniques such as the 16S ribosomal RNA 
sequencing can increase the sensitivity and expedite the isolation from clinical specimens.13 
Nevertheless, specimen collection usually requires invasive sampling. Noninvasive 
immunodiagnostic assays with different antigens have shown promising results, but remain 
commercially and widely unavailable.6,12,14 Prospective studies are required to further validate and 
facilitate wider adoption of these noninvasive diagnostic tests for childhood NTM lymphadenitis. 
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It is commonly assumed that the natural course of NTM lymphadenitis includes fistulization and 
drainage, typically lasting for months. In our data, however, 27% of the patients in the observation 
group did not develop a fistula, and the majority with a fistula had intermittent secretions for only 
days or weeks. Due to the novel blood test, and low TB incidence in Finland, invasive FNB was 
avoidable in most case. In an observational cohort study where FNB was part of the diagnostic 
protocol, fistulization rate was 97%.4 It has been speculated whether a puncture through intact skin 
could contribute to fistulization. In our study, a small difference was observed in fistulization 
between the groups with or without FNB (79% vs. 68%, respectively). In some patients, the 
reported fistulization may have initiated several weeks after FNB. Therefore, clear causality 
between FNB and fistula formation could not be determined.  
In some cases incision and curettage was performed in order to empty surgically a large lymph node 
which had already indured the skin and was draining, but the area of the indured skin was wide and 
the location of the lymph node was such that removal f the whole lymph node would have been 
excessive and pose a high risk of complication. Our clinical experience suggests that if we are able 
to remove necrotic tissue from the lymph node, there is less tissue to drain which may shorten the 
draining period. The distribution of draining period was similar comparing the curettage group to 
observation group, but the number of patients were too small and curettage group too heterogenic 
for statistical analysis. A prospective study with larger population would be needed to study 
whether curettage will significantly shorten the drainage.     
Patients included in the study underwent surgery for various reasons; to obtain a bacterial or 
histological specimen, as a curative treatment, or as a treatment for prolonged drainage. Thus, the 
surgery group was heterogenic. If the surgical treatm nt was deemed excessive (i.e. several affected 
lymph nodes) or if the risk of the facial nerve damage high, surgery was not performed. Parental 
opinion also affected the treatment choice. Parental involvement in the treatment decision process is 
important; a holistic approach should include education of the whole family about this non-severe 
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infection and its natural course. We recommend that the ORL specialist and parents decide on 
surgical treatment together unless there is a medical reason for or against surgery. We have not 
collected qualitative data on how the treatment, fis ul zation and duration of drainage effected the 
quality of life of the families. In general, our impression is that many parents prefer follow-up over 
surgery and the families cope well with the symptoms when given sufficient information, regular 
follow-up visits, and the possibility to get in touch with the treating clinician if needed. A recent 
report from Israel supports this view.15 In low-incidence settings, centralizing children with NTM 
lymphadenitis is beneficial and improves communication between different specialties. 
 
5. Conclusion  
Our current treatment protocol of childhood NTM lymphadenitis, surgery or observation alone, 
seems to be applicable also in the future. This study has shown that there were no major 
complications in either of the groups, and the majority f our patients in the observation group did 
not have excessive or prolonged drainage. 
Due to the tedious nature of the disease and diagnostic uncertainty, childhood NTM lymphadenitis 
can cause concern for the family as well as the clinician. Nevertheless, primum non nocere – above 
all, do no harm. After instituting the novel blood-based test to our diagnostic scheme, invasive 
investigations have become avoidable in the majority f cases. Furthermore, when deciding on the 
treatment approach, preventing major complications such as facial paresis must be a priority. 
Careful assessment and selection of patient that undergo surgery is crucial. Excision is an effective 
treatment in selected patients, but treating NTM lymphadenitis with observation alone, i.e. no 
antibiotics, is a good alternative to surgery. Informing the family about the natural course of the 
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Table 1. Clinical characteristics, diagnostic methods, and treatment of children with 
cervicofacial nontuberculous mycobacteria (NTM) lymphadenitis. 
No. %† 
Total no. of patients 52 100 
Female 33 63 
Age at presentation, years, median (range) 2.9 (1.1-7. )   
Duration of symptoms before the first contact, 




Pediatrics 5 10 
ENT 7 13 
Both 40 77 
Location of the infected lymphnodes 
Facial 7 13 
Upper neck/chin 23 44 
Mid/lower neck 16 31 
Multifocal lesions 6 12 
Method of NTM diagnosis‡ 
Culture and T-SPOT.TB positive 17 33 
Culture positive, T-SPOT.TB not analyzed 3 6 
Culture negative, T-SPOT.TB positive 14 27 
No culture, T-SPOT.TB positive 18 35 
Histological examination performed 24 46 
Treatment 
Surgery 19 37 
Observation 33 63 
Follow-up, median 
Active, months 8.2 
Passive, years‡ 3.7   
Visits to hospital, median (range) 
Total 6 (1-15) 
Surgery group 8 (3-15) 
Observation group 5 (1-15)   
† % of all 52 study patients 
‡ Up until May 31st 2018 
 
Table 2. Duration of (intermittent) drainage and involvement of fine needle biopsy of children infected by nontuberculous mycobacteria (NTM) 
in the observation-only group.  
Fine needle biopsy obtained No fine needle biopsy Total (%)† 
Duration of drainage No.‡ NTM species No. NTM species§ 
 
None 3 1 M. avium, 2 insufficient sample 6 nd 9 (27%) 
< 2 weeks 1 1 M. malmoense 4 nd 5 (15%) 
2 weeks –2 months 4 1 M. avium, 1 acid fast rod, 2 negative 4 1 M. malmoense, 1 negative, 2 nd 8 (24%) 
2–6 months 3 2 M. avium, 1 negative 4 1 M. avium, 3 negative 7 (21%) 
6-12 months 2 2 M. avium 0   2 (6%) 
Not determined 1 1 M. avium 1 nd 2 (6%) 
Total 14 19 33 (100%) 
† % Percentage of all patients in the observation-only group 
‡ No. of patients 
§ Bacterial culture was obtained from the draining f stula 
nd = not determined, no samples for culture available  
 
Table 3. Choice of treatment, complications, and duration of drainage of children with 
nontuberculous mycobacteria lymphadenitis treated with surgery. 
Incision and curettage 
No. of patients (%) 
Excision† 
No. of patients (%) 
 
Initial surgery 13 6 
Re-operation 1  1 
Postoperative infection or hematoma 0 3 
Duration of drainage after surgery 
None 3 (23%) 4 (67%) 
< 2 weeks 3 (23%) 2 (33%)‡ 
2 weeks –2 months 4 (31%) 0 
2–6 months 2 (15%) 0 
6-12 months 1 (8%)§ 0 
† Excision of the whole lymph node(s) 
‡ One postoperative hematoma and one drainage after second operation (curettage) 
§ Curettage was done twice because of prolonged secretion 

